Amplia Therapeutics Limited (ATX.AX)
AUD 0.05
(-1.89%)
AUD 0.05
(-1.89%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 14.84 Million AUD | -20.55% |
| 2023 | 18.68 Million AUD | -23.69% |
| 2022 | 24.48 Million AUD | 125.05% |
| 2021 | 10.87 Million AUD | 19.34% |
| 2020 | 9.11 Million AUD | -0.82% |
| 2019 | 9.19 Million AUD | 247.67% |
| 2018 | 2.64 Million AUD | -64.92% |
| 2017 | 7.53 Million AUD | 49.7% |
| 2016 | 5.03 Million AUD | -5.35% |
| 2015 | 5.31 Million AUD | -47.73% |
| 2014 | 10.17 Million AUD | -10.94% |
| 2013 | 11.42 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 14.84 Million AUD | -20.55% |
| 2024 Q2 | 17.55 Million AUD | 0.0% |
| 2024 Q4 | 14.84 Million AUD | 0.0% |
| 2023 Q4 | 18.68 Million AUD | 0.0% |
| 2023 Q2 | 21.83 Million AUD | 0.0% |
| 2023 FY | 18.68 Million AUD | -23.69% |
| 2022 FY | 24.48 Million AUD | 125.05% |
| 2022 Q2 | 12.96 Million AUD | 0.0% |
| 2022 Q4 | 24.48 Million AUD | 0.0% |
| 2021 Q4 | 10.87 Million AUD | 0.0% |
| 2021 Q2 | 12.61 Million AUD | 0.0% |
| 2021 FY | 10.87 Million AUD | 19.34% |
| 2020 Q4 | 9.11 Million AUD | 0.0% |
| 2020 Q2 | 9.19 Million AUD | 0.0% |
| 2020 FY | 9.11 Million AUD | -0.82% |
| 2019 Q2 | 9.86 Million AUD | 0.0% |
| 2019 Q4 | 9.19 Million AUD | 0.0% |
| 2019 FY | 9.19 Million AUD | 247.67% |
| 2018 Q4 | 2.64 Million AUD | 0.0% |
| 2018 FY | 2.64 Million AUD | -64.92% |
| 2018 Q2 | 4.68 Million AUD | 0.0% |
| 2017 Q2 | 8.93 Million AUD | 0.0% |
| 2017 FY | 7.53 Million AUD | 49.7% |
| 2017 Q4 | 7.53 Million AUD | 0.0% |
| 2016 Q2 | 3.18 Million AUD | 0.0% |
| 2016 Q4 | 5.03 Million AUD | 0.0% |
| 2016 FY | 5.03 Million AUD | -5.35% |
| 2015 Q3 | 5.31 Million AUD | -31.5% |
| 2015 Q2 | 7.76 Million AUD | 0.0% |
| 2015 Q1 | 7.76 Million AUD | 0.0% |
| 2015 FY | 5.31 Million AUD | -47.73% |
| 2015 Q4 | 5.31 Million AUD | 0.0% |
| 2014 Q1 | 3.8 Million AUD | 0.0% |
| 2014 FY | 10.17 Million AUD | -10.94% |
| 2013 FY | 11.42 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -166.375% |
| Acrux Limited | 8.96 Million AUD | -65.627% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 86.8% |
| BTC Health Limited | 5.14 Million AUD | -188.321% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 2.803% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 90.4% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 93.577% |
| Biome Australia Limited | 8.27 Million AUD | -79.358% |
| Hexima Limited | 2.26 Million AUD | -554.257% |
| Immutep Limited | 147.44 Million AUD | 89.932% |
| Memphasys Limited | 12.43 Million AUD | -19.428% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 94.013% |
| Noxopharm Limited | 6.78 Million AUD | -118.833% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 27.204% |
| Race Oncology Limited | 20.22 Million AUD | 26.613% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 79.392% |
| Starpharma Holdings Limited | 36.81 Million AUD | 59.675% |
| Tissue Repair Ltd | 19.38 Million AUD | 23.438% |
| Biotron Limited | 493.47 Thousand AUD | -2908.274% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 22.777% |
| CSL Limited | 56.93 Billion AUD | 99.974% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 41.902% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -788.172% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -369.843% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -186.396% |
| Patrys Limited | 4.16 Million AUD | -256.718% |
| Orthocell Limited | 26.61 Million AUD | 44.223% |
| Imugene Limited | 151.39 Million AUD | 90.195% |
| PYC Therapeutics Limited | 91.23 Million AUD | 83.729% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -36.505% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -76.974% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -11.746% |
| Nanollose Limited | 241.95 Thousand AUD | -6035.584% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -142.565% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -173.095% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -478.876% |
| Nyrada Inc. | 5.9 Million AUD | -151.303% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 96.273% |
| Dimerix Limited | 32.07 Million AUD | 53.723% |
| PharmAust Limited | 11.12 Million AUD | -33.441% |
| AnteoTech Limited | 9.38 Million AUD | -58.244% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 45.802% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -133.061% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -102.821% |
| Actinogen Medical Limited | 21.31 Million AUD | 30.343% |
| Immuron Limited | 15.54 Million AUD | 4.533% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 9.357% |